Main > DERMATOLOGY > AU. C. EPP>Treat.>Alpha MSH Analog>

---

ue Implant

AU. C. EPP>Treat.>Alpha MSH Analog>'s subsections
(*) CN Launch Date: 2020. 04.23.
(*) EU CE Mark Date: 2014. 12.
(*) USA Launch Date: 2020. 04.16.
Company
Generic Name: Afamelanotide 16mg
MSH: melanocyte stimulating hormone
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 06.01.
RTM
Web-Site

AU. C. EPP>Treat.>Alpha MSH Analog>'s products
This section has no products